Atlas Trials

Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment

Clinical trial NCT01851018 · UNKNOWN

Trial details

NCT number
NCT01851018
Sponsor
CHU de Quebec-Universite Laval
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2012-05-01
Primary completion
2024-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.